Mymetics Corporation
MYMX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -91.4% | -68.5% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | -47,966.7% | -32,400% | -2,914.3% | -773.9% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | -$1 | -$2 | -$1 |
| Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Income | -$2 | -$2 | -$2 | -$1 |
| % Margin | -58,166.7% | -55,000% | -4,497.1% | -1,244.1% |
| Other Income/Exp. Net | -$3 | -$3 | -$3 | -$3 |
| Pre-Tax Income | -$5 | -$5 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$5 | -$4 | -$4 |
| % Margin | -160,166.7% | -157,666.7% | -11,880% | -3,772.1% |
| EPS | -0.016 | -0.024 | -0.014 | -0.014 |
| % Growth | 32.8% | -71.5% | 0.7% | – |
| EPS Diluted | -40 | -0.024 | -0.014 | -0.014 |
| Weighted Avg Shares Out | 304 | 304 | 304 | 304 |
| Weighted Avg Shares Out Dil | 304 | 304 | 304 | 304 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $3 | $3 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$1 | -$1 |
| % Margin | -66,333.3% | -65,333.3% | -4,091.4% | -1,325.2% |